Lung Cancer News

Osimertinib significantly prolonged OS compared with previous standard-of-care first-line therapies for patients with locally advanced or metastatic, EGFR-mutated non-small cell lung cancer, according to the agent’s manufacturer.

Nonsmoking workers in states without comprehensive smoke-free laws are more likely to be frequently exposed to workplace secondhand smoke than workers in states with comprehensive smoke-free laws, according to findings published in Morbidity and Mortality Weekly Report.

The Parker Institute for Cancer Immunotherapy, in collaboration with the Juvenile Diabetes Research Foundation and Helmsley Charitable Trust, have formed a cancer and diabetes research initiative to better understand the association between immunotherapy treatment and subsequent risk for type 1 diabetes.

Today marks World Lung Cancer Day.

GO2 Foundation for Lung Cancer presented Solange Peters, MD, PhD, with the Bonnie J. Addario Lectureship Award.

The FDA granted orphan drug designation to durvalumab for the treatment of small cell lung cancer.

Approximately half of current smokers in a recent survey reported seeing federal court-ordered antismoking advertisements, but exposure to these advertisements fell short in some U.S. populations, including in those who are at higher risk for tobacco use, researchers reported in JAMA Network Open.

Reductions in lung cancer mortality with low-dose CT screening vs. chest X-ray among participants in the National Lung Screening Trial have been sustained over extended follow-up, according to results of an updated analysis of the trial published in Journal of Thoracic Oncology.

When added to combination therapy with cisplatin plus pemetrexed, nintedanib did not improve progression-free survival in patients with malignant pleural mesothelioma who had not been treated with chemotherapy, according to the phase 3 part of the LUME-Meso trial.

The San Francisco Board of Supervisors unanimously passed an ordinance to amend the city’s health code to prohibit sale of electronic cigarettes and flavored tobacco products whose marketing has not received FDA approval.